Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study by Lenka N. C. Boyd, Lenka N. C. Boyd, Lenka N. C. Boyd, Lynn E. Nooijen, Lynn E. Nooijen, Lynn E. Nooijen, Mahsoem Ali, Mahsoem Ali, Mahsoem Ali, Jisce R. Puik, Jisce R. Puik, Jisce R. Puik, Jasmine Moustaquim, Stephanie M. Fraga Rodrigues, Stephanie M. Fraga Rodrigues, Stephanie M. Fraga Rodrigues, Robert Broos, Robert Broos, Robert Broos, Ali Belkouz, Laura L. Meijer, Tessa Y. S. Le Large, Tessa Y. S. Le Large, Tessa Y. S. Le Large, Joris I. Erdmann, Gerrit K. J. Hooijer, Michal Heger, Michal Heger, Michal Heger, Hanneke W. M. Van Laarhoven, Hanneke W. M. Van Laarhoven, Eva Roos, Geert Kazemier, Geert Kazemier, Elisa Giovannetti, Elisa Giovannetti, Elisa Giovannetti, Joanne Verheij, Heinz-Josef Klümpen

Connect to this object online.

Development of a set of patient reported outcome measures for patients with benign liver tumours and cysts: patient focus groups and systematic review by Alicia Furumaya, Lynn E. Nooijen, Martijn P. D. Haring, Hedy A. van Oers, Marlou van Beneden, Belle V. van Rosmalen, R. Bart Takkenberg, Geert Kazemier, Marc G. Besselink, Vincent E. de Meijer, Joris I. Erdmann, the Dutch Benign Liver Tumor Group

Connect to this object online.